Article
Single-cell panleukemia signatures of HSPC-like blasts predict drug response and clinical outcome
16 Mar 2025
Abstract excerpt
ABSTRACT: The critical role of leukemia-initiating cells as a therapy-resistant population in myeloid leukemia is well established. However, the molecular signatures of such cells in acute lymphoblastic leukemia remain underexplored. Moreover, their role in therapy response and patient prognosis is yet to be systematically investigated across various types of acute leukemia. We used single-cell multiomics to...
Topics
Join the communities discussing this publication.
